Pharma Journalist - Page 2 of 844 -

FDA Approves Alnylam’s AMVUTTRA for ATTR-CM

Bristol Myers Squibb Gains EU Approval to Expand Breyanzi CAR T Therapy for Follicular Lymphoma

Latigo Biotherapeutics Secures $150 Million in Series B Funding to Propel Development of Non-Opioid Pain Treatments

Azurity Pharmaceuticals Acquires Covis Pharma

Zealand Pharma and Roche Partner to Co-Develop Petrelintide for Overweight and Obesity Treatment

Merck Reports Positive Phase 3 Data for Doravirine/Islatravir (DOR/ISL) in HIV-1 Treatment

Vivace Therapeutics Secures $35 Million in Series D to Advance First-in-Class Cancer Drug

Emergent BioSolutions and Rocketvax Announce Investment Agreement to Advance Next-Generation Product Candidates

ElevateBio Partners with AWS to Enhance CRISPR Gene Editing with Generative AI

Lundbeck’s MSA Treatment Receives Orphan Drug Designation in Japan

WAINZUA (eplontersen) Approved in the EU for Hereditary Transthyretin-Mediated Amyloidosis